Biome Grow (CSE:BIO,OTCQB:BIOIF,FWB:6OTA) CEO Khurram Malik believes the company’s experience in building vertically integrated cannabis operations in Canada will be beneficial to expanding its international presence.

In the interview below, Malik talked about the advantages of being a small-cap company that can make large-cap deals without spending hundreds of millions of dollars in the process. One of the reasons for Biome’s recent success is its vertically integrated operations. He pointed out that cannabis companies typically become vertically integrated over time in order to be successful. Biome, on the other hand, ensured that they were covering all verticals from the start.

If the company can execute its business model, Malik believes that Biome could become a major cannabis company within the next two years.

Malik also provided an overview of the company’s long-term goals, which include becoming a global medical cannabis company. He believes that the real opportunity for Biome is in the global medical cannabis market. He points out that Canada is home to only 36 million people, and there are countries abroad that have twice the size of Canada’s population. Until Biome goes international, however, the company will be focusing on filling gaps in the Canadian market, such as creating cannabis brands that are unique to each province.

Below is a transcript of our interview with Biome Grow CEO Khurram Malik. It has been edited for clarity and brevity.

Investing News Network: Please provide an overview of Biome Grow.

Biome Grow CEO Khurram Malik: Biome is a Toronto-based cannabis company with domestic operations in Atlantic Canada. We’ll have an international focus later this year as this is where the bulk of our business will come from moving forward.

INN: How does Biome approach business as a small-cap company making large-cap deals?

KM: We’ve designed Biome to be very efficient despite having a small footprint, which allows us to secure large deals that generate large cash flow without spending hundreds of millions of dollars to secure these deals. We’re also regulatory specialists who have helped build some of the largest cannabis companies in Canada because we know how to navigate the supplier and offtake side of things.

INN: How important is vertical integration to Biome’s development?

KM: We’ve been vertically integrated since day one, which is unusual. Typically, most companies don’t do this at the start and pick it up as they grow. We’ve been working in this industry for a long time and have helped build vertically integrated platforms before. We know how to do these things simultaneously. We know where the pitfalls, pivot points and pain points are, and we can deal with them quickly and efficiently. If we do our job correctly, Biome could become a major company within the next two years.

INN: What is the focus of Biome’s long-term business strategy?

KM: Our long-term strategy is to export Canadian cannabis and brands overseas. We want to be known as a global medical cannabis company that has production, retail, regulatory and educational assets. Canada is our home base and where we started.

INN: How important is medical cannabis to Biome’s future?

KM: It’s very important. We prefer the medical market over the recreational market because the margins are thicker, there are greater barriers to entry and there are more innovations to be made. There’s also less competition and more sustainable control over your destiny. Additionally, the world is moving towards medical programs — not recreational. There are only 36 million people in Canada. It’s a great but small market and only a starting point for us. The real prize resides in global markets that are serving hundreds of millions of people.

INN: How does Biome plan to differentiate itself from similar cannabis companies?

KM: The Canadian cannabis market is in its early stages, and no one has established the right way of doing things. We’re trying to identify the gaps in the system and fill them. In Canada, that gap is provincial brands. In overseas markets, it’s licensed producers. Many large countries also need help in establishing their regulations and cannabis programs. We’re helping them define those regulations and programs based on what we’ve learned in Canada. We have an entry niche in Canada, and being a first mover in these large countries coming online is just the beginning for Biome.

This interview provides information which was sourced by the Investing News Network (INN) and approved by Biome Grow, in order to help investors learn more about the company. Biome Grow is a client of INN. 

INN does not provide investment advice and the information on this profile should not be considered a recommendation to buy or sell any security. INN does not endorse or recommend the business, products, services or securities of any company profiled.

The information contained here is for information purposes only and is not to be construed as an offer or solicitation for the sale or purchase of securities. Readers should conduct their own research for all information publicly available concerning the company. Prior to making any investment decision, it is recommended that readers consult directly with Biome Grow and seek advice from a qualified investment advisor.

This interview may contain forward-looking statements including but not limited to comments regarding the timing and content of upcoming work programs, receipt of property titles, etc. Forward-looking statements address future events and conditions and therefore involve inherent risks and uncertainties. Actual results may differ materially from those currently anticipated in such statements. The issuer relies upon litigation protection for forward-looking statements. Investing in companies comes with uncertainties as market values can fluctuate.

TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) (“TransCanna” or the “Company”) is pleased to announce that it has closed the 2nd and final tranche of its Unit financing. In connection with the closing, the Company issued 1,356,873 Units at a price of $0.55 per Unit, for gross proceeds of $746,280.15. Each Unit consists of one (1) common share and one (1) warrant. Each warrant entitles the holder to purchase one common share of the Company, at an exercise price of $0.75 per share, for a period of two years from the date of issuance. The warrants are subject to an acceleration right that allows the Company to give notice of an earlier expiry date if the Company’s share price on the CSE (or such other stock exchange the Company’s shares may be trading on) is equal to or greater than $1.25 for a period of 20 consecutive trading days. Finder’s fees of $42,542, 3,200 Finder’s shares and 80,550 Finder’s warrants were issued in connection with finder’s fees payable.

In total, the Company raised gross proceeds of $1,757,180 and issued 3,194,873 Units.

Keep reading... Show less

 Sweet Earth Holdings Corp. (CSE: SE) (FSE: 1KZ1) (OTCQB: SEHCF) (“Sweet Earth” the “Company”) is pleased to announce that it has received full Depository Trust Company (“DTC”) eligibility in the United States. On October 20, 2020, Sweet Earth announced that its shares had been listed on the United States’ Over-The-Counter Bulletin (“OTCQB”) under the ticker SEHCF.

DTC status means that Sweet Earth shares are now eligible to be transferred between brokerage accounts within the United States and significantly augments the ease in which American-based investors are able to trade Sweet Earth shares.

Keep reading... Show less

Hill Street Beverage Company Inc. (TSXV: BEER) (“Hill Street” or the “Company”), announces that further to its press releases dated July 21, 2020 and July 31, 2020, the Company proposes to amend the exercise price of 19,405,804 warrants of the Company that were originally issued on July 27, 2018, to $0.10. These warrants are set to expire on December 31, 2020.

The Company had initially proposed a lower amended price, but that proposal was not approved by the TSX Venture Exchange (“Exchange“), however, the Exchange indicated that a $0.10 exercise price, may be more acceptable. Accordingly, the proposed amendment remains subject to Exchange approval.

Keep reading... Show less

Issuance of U.S. Patent No. 10,851,077 covering methods for extracting and concentrating cannabinoids using ultrasound-enhanced solvent extraction bolsters World Class’ intellectual patent portfolio

World-Class Extractions Inc. (CSE:PUMP)(FRA:WCF)(OTCQB:WCEXF) (the “Company” or “World-Class”) is pleased to announced the United States Patent and Trademark Office (“USPTO”) has issued U.S. Patent No. 10,851,077 on December 1, 2020 in relation to the Company’s methods for extracting and concentrating cannabinoids and other target compounds from cannabis using ultrasound-enhanced solvent extraction

Keep reading... Show less

Ubican brings well-known brands and is a trusted vendor with an established sales and marketing program

Chemesis International Inc. (CSE:CSI) (OTCQB:CADMF) (FRA:CWAA) (the “Company” or “Chemesis”), announces Ubican Global (“Ubican”) as its primary supplier for its United States VICKI program. Ubican is a trusted supplier of a family of brands, each with multiple types of products. The products include tinctures, digestibles, edibles, pet, beautyskincare, topical, edible, fitness, and smokable products

Keep reading... Show less